Study finds significant variability in treatment access for patients with malignant pleural mesothelioma

Study finds significant variability in treatment access for patients with malignant pleural mesothelioma

A study of 2,804 patients with stage I to stage III malignant pleural mesothelioma (MPM) found signi...
read more
Durvalumab combined with chemotherapy improves overall survival in patients with lung cancer: First-line treatment reduces mortality risk by 27%

Durvalumab combined with chemotherapy improves overall survival in patients with lung cancer: First-line treatment reduces mortality risk by 27%

Adding immunotherapy in the form of durvalumab to ...
read more
Discovery of distinct lung cancer pathways may lead to more targeted treatments

Discovery of distinct lung cancer pathways may lead to more targeted treatments

Known for its poor prognosis, lung adenocarcinoma ...
read more